
Sign up to save your podcasts
Or
In this episode, Dr Ravina Kullar, an infectious disease pharmacist, epidemiologist and research consultant, and Prof. Helen Fletcher, Professor of Immunology at the London School of Hygiene & Tropical Medicine, come together virtually to discuss the role of T cells in vaccine development.
During this 30-minute educational podcast, our experts explain the basics of vaccines: what they are, how they are developed and why they are so important to global public health. Dr Kullar and Prof. Fletcher discuss the mechanisms of immunity, how T cell and antibody responses are generated by the body, and how vaccine development programmes can harness T cell and antibody responses using diagnostic assays. Our speakers highlight the importance of having QC-validated, standardised T cell response assays available, and provide an overview of the roles T cell responses may play in vaccine development.
This podcast was developed by the Global T cell Expert Consortium (GTEC), an initiative set up to bring together experts in T cells, vaccines, immunology and public health worldwide, with the aim of becoming the leading voice in T cell research during and beyond the current COVID-19 pandemic. The GTEC will educate on T cells and vaccine development through the release of publicly available educational content, and foster collaborative research efforts to address the unmet needs and unanswered questions in T cell research and vaccinology. This initiative is sponsored by Oxford Immunotec.
In this episode, Dr Ravina Kullar, an infectious disease pharmacist, epidemiologist and research consultant, and Prof. Helen Fletcher, Professor of Immunology at the London School of Hygiene & Tropical Medicine, come together virtually to discuss the role of T cells in vaccine development.
During this 30-minute educational podcast, our experts explain the basics of vaccines: what they are, how they are developed and why they are so important to global public health. Dr Kullar and Prof. Fletcher discuss the mechanisms of immunity, how T cell and antibody responses are generated by the body, and how vaccine development programmes can harness T cell and antibody responses using diagnostic assays. Our speakers highlight the importance of having QC-validated, standardised T cell response assays available, and provide an overview of the roles T cell responses may play in vaccine development.
This podcast was developed by the Global T cell Expert Consortium (GTEC), an initiative set up to bring together experts in T cells, vaccines, immunology and public health worldwide, with the aim of becoming the leading voice in T cell research during and beyond the current COVID-19 pandemic. The GTEC will educate on T cells and vaccine development through the release of publicly available educational content, and foster collaborative research efforts to address the unmet needs and unanswered questions in T cell research and vaccinology. This initiative is sponsored by Oxford Immunotec.